Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Bode

Showing results (371-380 of 600) with videos related to

Pageof 60
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|December 31, 2002
Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1Michiel Voskuil, Niels van Royen, Imo E Hoefer, et al.
Atherosclerosis|July 26, 2005
Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytesImo E Hoefer, Sebastian Grundmann, Niels van Royen, et al.
American Heart Journal|May 17, 2011
Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndromeC Michael Gibson, Jessica L Mega, Paul Burton, et al.
Cureus|March 17, 2021
Intensive Care Resources and 60-Day Survival of Critically-Ill COVID-19 PatientsCorinna N Lang, Viviane Zotzmann, Bonaventura Schmid, et al.
Plos One|October 24, 2019
Inflammation in acute coronary syndrome: Expression of TLR2 mRNA is increased in platelets of patients with ACSLukas Andreas Heger, Marcus Hortmann, Madlin Albrecht, et al.
Thrombosis and Haemostasis|March 12, 2009
Desmoteplase in acute massive pulmonary thromboembolismUlrich Tebbe, Peter Bramlage, Andreas Graf, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|June 16, 2020
Bioresorbable zinc stent with ultra-thin center struts attenuates stent jail in porcine femoral artery bifurcationsChristoph Hehrlein, Björn Schorch, Jörg Haberstroh, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 25, 2017
Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacementAnja Gutmann, Klaus Kaier, Holger Reinecke, et al.
Circulation|May 16, 2007
Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trialMarc Cohen, Deepak L Bhatt, John H Alexander, et al.
Membranes|April 30, 2021
Mode of Death after Extracorporeal Cardiopulmonary ResuscitationViviane Zotzmann, Corinna N Lang, Xavier Bemtgen, et al.
Pageof 60

Showing results (371-380 of 600) with videos related to

Sort By:
Pageof 60
American Journal of Physiology. Heart and Circulatory Physiology|December 31, 2002
Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1Michiel Voskuil, Niels van Royen, Imo E Hoefer, et al.
Atherosclerosis|July 26, 2005
Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytesImo E Hoefer, Sebastian Grundmann, Niels van Royen, et al.
American Heart Journal|May 17, 2011
Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndromeC Michael Gibson, Jessica L Mega, Paul Burton, et al.
Cureus|March 17, 2021
Intensive Care Resources and 60-Day Survival of Critically-Ill COVID-19 PatientsCorinna N Lang, Viviane Zotzmann, Bonaventura Schmid, et al.
Plos One|October 24, 2019
Inflammation in acute coronary syndrome: Expression of TLR2 mRNA is increased in platelets of patients with ACSLukas Andreas Heger, Marcus Hortmann, Madlin Albrecht, et al.
Thrombosis and Haemostasis|March 12, 2009
Desmoteplase in acute massive pulmonary thromboembolismUlrich Tebbe, Peter Bramlage, Andreas Graf, et al.
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|June 16, 2020
Bioresorbable zinc stent with ultra-thin center struts attenuates stent jail in porcine femoral artery bifurcationsChristoph Hehrlein, Björn Schorch, Jörg Haberstroh, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 25, 2017
Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacementAnja Gutmann, Klaus Kaier, Holger Reinecke, et al.
Circulation|May 16, 2007
Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention: the SEPIA-PCI trialMarc Cohen, Deepak L Bhatt, John H Alexander, et al.
Membranes|April 30, 2021
Mode of Death after Extracorporeal Cardiopulmonary ResuscitationViviane Zotzmann, Corinna N Lang, Xavier Bemtgen, et al.
Pageof 60